ISB News

The Future of Health: Presentations from ISB’s 17th Annual International Symposium

At our 17th Annual International Symposium, focusing on the Future of Health, we welcomed speakers who are experts in diverse areas including environmental and occupational health, infectious disease transmission and forecast, drug and vaccine development, communicable disease dynamics, and beyond.

Our presenters spoke during three sessions:

  • Population health, which focused on global health informatics and how big data can be used to understand the health of middle- and low-income populations; metabolic disease and the epidemiology of obesity; and the impact of personalized medicine on population health
  • Early warning systems, which explored dynamic, data-driven modeling; environmental determinants of infectious disease transmission and modeling effects of climate change and environment on pathogen dynamics; and the tipping points for the emergence – and re-emergence – of infectious diseases
  • and Prevention and Therapy, which tackled research on host-pathogen interactions and the genetic determinants of infectious disease, innate immunity, antimicrobial resistance and vaccine development.

Following are the recorded presentations from our two-day event.

Keynote address

Howard Frumkin, Dr.P.H., M.P.H, M.D.
Presentation title: The Fifth P: Planetary Change and the Future of Human Health

Session 1: Population Health

Lee Hood, M.D., Ph.D.
Presentation title: A Systems-Driven View of Population Health Anchored in Understanding the Individual

Gilla Kaplan, Ph.D.
Presentation title: Discovery and Development of New Tools to Improve Management of the TB Epidemic

Leo Anthony Celi, Ph.D.
Presentation title: The Challenge of Medical Artificial Intelligence

Theo Vos, M.D., Ph.D.
Presentation title: Forecasting Global Burden of Disease Estimates

Population Health panel discussion

Session 2: Early Warning Systems

Jeffrey Shaman, Ph.D.
Presentation title: Forecasting the Growth and Spread of Infectious Disease Outbreaks

Stephen A. Williams, M.D., Ph.D.
Presentation title: What Will We Learn from a Billion Protein Measurements?

Jennifer Gardy, Ph.D.
Presentation title: Towards a Genomics-Informed Digital Pathogen Surveillance System

Trevor Bedford, Ph.D.
Presentation title: Real-time Tracking of Virus Evolution

Early Warning Systems panel discussion

Session 3: Prevention and Therapy

Marc Lipsitch, Ph.D.
Presentation title: Why Haven’t Drug-Resistant Bacteria Taken Over the World?

Anushree Chatterjee, Ph.D.
Presentation title: From Synthetic Biology to Nanobiotechnology: Rational Antimicrobial Engineering Approaches for Combating Multidrug-Resistant Pathogens

Tanya Parish, Ph.D.
Presentation title: Can We Solve Antimicrobial Resistance with Current Approaches?

Julie McElrath, M.D., Ph.D.
Presentation title: Prospects for an Effective HIV Vaccine

Prevention and Therapy panel discussion

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.